Diagnostic biomarkers for stratification of COVID-19 patients and prediction of prognostic severity.
Prediction of the efficacy of cancer immunotherapy using the tumor-targeting activity of T cells in peripheral blood.
Biomarkers for prediction and diagnosis of interstitial pneumonia, a side effect of cancer treatment with immune checkpoint inhibitors
POI could be diagnosed by detecting autoantibody reacting to POTE proteins expressing in ovarian tissue
One Step N-terminal Ligation with Functional Compounds
Screening test for early stage gastric cancer, esophageal cancer and colorectal cancer patients by measuring urine miRNAs specific to each cancer.